# FTH (Faeth Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Faeth Therapeutics, Inc. reported $178.9M in total assets and a net loss of $211.4M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/FTH
- Markdown: https://convexityos.com/fundamentals/FTH.md
- SEC CIK: 0001829802
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001829802&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$216.1M | Operating profit |
| Net Income | FY 2025 | -$211.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$8.18 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$43.28M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $174.8M | Total debt: $145K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $22.29M | $32.61M | $37.06M | $50.19M | $37.48M | $19.45M |
| **Operating Income** | -$22.29M | -$32.61M | -$37.06M | -$50.19M | -$37.48M | -$19.45M |
| **EBITDA** | -$22.17M | -$32.06M | -$36.49M | -$49.57M | -$36.80M | -$19.24M |
| Interest Expense | $32K | $90K | $144K | $219K | $670K | $1.69M |
| Income Before Tax | -$21.09M | -$30.16M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- |
| **Net Income** | -$21.09M | -$30.16M | -$34.10M | -$48.59M | -$36.79M | -$20.10M |
| Basic EPS | -$16.72 | -$24.01 | -$24.40 | -$31.60 | -$26.60 | -$250.60 |
| **Diluted EPS** | -$16.72 | -$24.01 | -$24.40 | -$31.60 | -$26.60 | -$250.60 |
| Basic Shares Outstanding | 1.3M | 1.3M | 1.4M | 1.5M | 1.4M | 80.6K |
| Diluted Shares Outstanding | 1.3M | 1.3M | 1.4M | 1.5M | 1.4M | 80.6K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $22.09M | $18.39M | $170.6M | $4.96M | $4.85M | $5.21M | $7.27M | $8.27M |
| **Operating Income** | -$22.09M | -$18.39M | -$170.6M | -$4.96M | -$4.85M | -$5.21M | -$7.27M | -$8.27M |
| **EBITDA** | -$22.07M | -$18.36M | -$170.6M | -$4.93M | -$4.82M | -$5.17M | -$7.24M | -$8.13M |
| Interest Expense | -- | -- | -- | $3.0K | $6.0K | $10K | $13K | $17K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$20.40M | -$16.01M | -$170.2M | -$4.72M | -$4.57M | -$4.94M | -$6.86M | -$7.77M |
| Basic EPS | -$0.79 | -$2.84 | -$131.45 | -- | -$3.62 | -$3.91 | -$5.45 | -- |
| **Diluted EPS** | -$0.79 | -$2.84 | -$131.45 | -- | -$3.62 | -$3.91 | -$5.45 | -- |
| Basic Shares Outstanding | 25.8M | 5.6M | 1.3M | -- | 1.3M | 1.3M | 1.3M | -- |
| Diluted Shares Outstanding | 25.8M | 5.6M | 1.3M | -- | 1.3M | 1.3M | 1.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.67M | $9.99M | $13.01M | $17.80M | $7.16M | $16.60M |
| Short-Term Investments | $12.52M | $31.34M | $52.75M | $89.32M | $140.5M | -- |
| **Cash & Short-Term Investments** | $21.18M | $41.34M | $65.76M | $107.1M | $147.6M | $16.60M |
| Other Current Assets | $92K | $120K | $325K | $344K | $374K | -- |
| **Total Current Assets** | $21.51M | $41.93M | $67.25M | $108.6M | $148.5M | $20.08M |
| Property, Plant & Equipment, Net | $82K | $417K | $1.17M | $2.05M | $4.64M | $1.27M |
| Other Non-Current Assets | $18K | $48K | $86K | $63K | $39K | $86K |
| **Total Non-Current Assets** | $1.40M | $3.43M | $7.12M | $9.79M | $4.68M | $1.35M |
| **Total Assets** | $22.90M | $45.36M | $74.37M | $118.4M | $153.2M | $21.43M |
| Accounts Payable | $689K | $244K | $573K | -- | -- | -- |
| Other Current Liabilities | $77K | $126K | $221K | -- | -- | $948K |
| **Total Current Liabilities** | $4.25M | $5.45M | $5.64M | $9.07M | $4.89M | $4.83M |
| Long-Term Debt | -- | -- | -- | -- | -- | $567K |
| Other Non-Current Liabilities | $0 | -- | $67K | $0 | $149K | $52K |
| **Total Non-Current Liabilities** | $59K | $1.53M | $3.84M | $5.90M | $1.82M | $705K |
| **Total Liabilities** | $4.31M | $6.97M | $9.48M | $14.97M | $6.71M | $5.54M |
| **Total Debt (incl. Leases)** | $1.51M | $3.85M | $6.21M | $8.03M | $2.35M | $685K |
| Common Stock | $0 | $0 | $3.0K | $3.0K | $3.0K | -- |
| Retained Earnings | -$283.1M | -$262.1M | -$231.9M | -$197.8M | -$149.2M | -$112.4M |
| Accumulated Other Comp. Income | $1.0K | -$13K | -$209K | -$1.00M | -$333K | -- |
| **Total Stockholders' Equity** | $18.59M | $38.39M | $64.89M | $103.4M | $146.5M | -$56.44M |
| Total Equity | $18.59M | $38.39M | $64.89M | $103.4M | $146.5M | -$56.44M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.18M | $26.90M | $152.3M | $8.67M | $10.56M | $12.56M | $9.88M | $9.99M |
| Short-Term Investments | $160.6M | $159.5M | $50.47M | $12.52M | $14.48M | $16.07M | $24.45M | $31.34M |
| **Cash & Short-Term Investments** | $174.8M | $186.4M | $202.8M | $21.18M | $25.04M | $28.63M | $34.33M | $41.34M |
| Other Current Assets | $1.63M | $858K | $465K | $92K | $248K | $116K | $440K | $120K |
| **Total Current Assets** | $177.8M | $188.7M | $204.2M | $21.51M | $25.79M | $29.57M | $35.68M | $41.93M |
| Property, Plant & Equipment, Net | $1.0K | $44K | $69K | $82K | $112K | $143K | $159K | $417K |
| Goodwill | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $981K | $80K | $167K | $18K | $18K | $24K | $24K | $48K |
| **Total Non-Current Assets** | $1.11M | $648K | $1.15M | $1.40M | $1.80M | $2.21M | $2.59M | $3.43M |
| **Total Assets** | $178.9M | $189.3M | $205.4M | $22.90M | $27.59M | $31.78M | $38.27M | $45.36M |
| Accounts Payable | $2.99M | $2.15M | $3.42M | $689K | $306K | $351K | $361K | $244K |
| Other Current Liabilities | $223K | $175K | $136K | $77K | $80K | $76K | $75K | $126K |
| **Total Current Liabilities** | $11.03M | $9.58M | $14.19M | $4.25M | $4.44M | $3.87M | $5.23M | $5.45M |
| Other Non-Current Liabilities | $53K | $1.0K | $1.0K | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $53K | $1.0K | $1.0K | $59K | $146K | $596K | $1.06M | $1.53M |
| **Total Liabilities** | $11.09M | $9.58M | $14.19M | $4.31M | $4.58M | $4.47M | $6.29M | $6.97M |
| **Total Debt (incl. Leases)** | $145K | $592K | $1.04M | $1.51M | $2.02M | $2.56M | $3.21M | $3.85M |
| Common Stock | $3.0K | $2.0K | $0 | $0 | $0 | $0 | $3.0K | $0 |
| Retained Earnings | -$489.8M | -$469.4M | -$453.4M | -$283.1M | -$278.4M | -$273.9M | -$268.9M | -$262.1M |
| Accumulated Other Comp. Income | -$153K | -$63K | -$24K | $1.0K | -$3.0K | -$11K | -$6.0K | -$13K |
| **Total Stockholders' Equity** | $161.1M | $173.0M | -$137.3M | $18.59M | $23.01M | $27.31M | $31.99M | $38.39M |
| Total Equity | $161.1M | $173.0M | -$137.3M | $18.59M | $23.01M | $27.31M | $31.99M | $38.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.09M | -$30.16M | -$34.10M | -$48.59M | -$36.79M | -$20.10M |
| Depreciation & Amortization | $122K | $551K | $571K | $614K | $685K | $209K |
| Stock-Based Compensation | $1.27M | $3.13M | $4.45M | $5.81M | $5.66M | $1.49M |
| **Operating Cash Flow** | -$20.45M | -$24.67M | -$32.02M | -$39.03M | -$30.26M | -$17.70M |
| Capital Expenditure | -$16K | -$146K | -$180K | -$321K | -$2.03M | -$1.21M |
| **Free Cash Flow** | -$20.47M | -$24.82M | -$32.20M | -$39.35M | -$32.28M | -$18.91M |
| **Investing Cash Flow** | $19.77M | $22.44M | $38.41M | $49.95M | -$143.1M | -$1.40M |
| Share Repurchases | -- | -- | -$10.38M | -- | -- | -- |
| **Financing Cash Flow** | -$645K | -$787K | -$11.17M | -$287K | $163.9M | $35.45M |
| **Net Change in Cash** | -$1.33M | -$3.02M | -$4.78M | $10.64M | -$9.44M | $16.34M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$20.40M | -$16.01M | -$170.2M | -$4.72M | -$4.57M | -$4.94M | -$6.86M | -$7.77M |
| Depreciation & Amortization | $17K | $25K | $29K | $30K | $30K | $32K | $30K | $139K |
| Stock-Based Compensation | $8.52M | $4.48M | $12.90M | $295K | $254K | $264K | $461K | $391K |
| **Operating Cash Flow** | -$13.00M | -$15.67M | -$10.73M | -$3.86M | -$3.59M | -$5.91M | -$7.09M | -$5.79M |
| Capital Expenditure | -$3.0K | $0 | -$6.0K | $0 | $0 | -$16K | $0 | $0 |
| **Free Cash Flow** | -$13.01M | -$15.67M | -$10.74M | -$3.86M | -$3.59M | -$5.92M | -$7.09M | -$5.79M |
| Acquisitions, Net | $0 | $0 | $6.46M | -- | $0 | $0 | $0 | -- |
| **Investing Cash Flow** | $175K | -$108.1M | -$31.44M | $2.08M | $1.74M | $8.76M | $7.19M | -$3.15M |
| **Financing Cash Flow** | $104K | -$1.68M | $185.8M | -$111K | -$152K | -$168K | -$214K | -$194K |
| **Net Change in Cash** | -$12.72M | -$125.4M | $143.7M | -$1.89M | -$2.00M | $2.68M | -$117K | -$9.14M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -113.4% | -78.6% | -52.5% | -47.0% | -25.1% | -- |
| Return on Assets (ROA) | -92.1% | -66.5% | -45.9% | -41.0% | -24.0% | -93.8% |
| Current Ratio | 5.06x | 7.70x | 11.92x | 11.98x | 30.38x | 4.16x |
| Quick Ratio | 4.98x | 7.59x | 11.65x | 11.82x | 30.19x | 3.44x |
| Debt to Equity | 0.08x | 0.10x | 0.10x | 0.08x | 0.02x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -131.2% | -113.0% | -- | -113.4% | -104.9% | -98.2% | -90.8% | -78.6% |
| Return on Assets (ROA) | -118.1% | -103.3% | -89.8% | -92.1% | -87.5% | -84.4% | -75.8% | -66.5% |
| Current Ratio | 16.12x | 19.69x | 14.39x | 5.06x | 5.81x | 7.64x | 6.82x | 7.70x |
| Quick Ratio | 15.84x | 19.46x | 14.29x | 4.98x | 5.64x | 7.39x | 6.57x | 7.59x |
| Debt to Equity | 0.00x | 0.00x | -- | 0.08x | 0.09x | 0.09x | 0.10x | 0.10x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
